Male Fertility: Production, Pathology & Laboratory Evaluation

Sperm Production & Maturation

  • Site of production: seminiferous tubules (testes)
    • During spermatogenesis histones are replaced by protamines → first wave of nuclear chromatin compaction.
  • Post-testicular maturation: epididymal transit
    • Path: caput (upper) → corpus (central) → cauda (lower, storage until ejaculation)
    • Additional chromatin compaction & acquisition of progressive motility.
  • Total time for one cycle of spermatogenesis ≈ 74 days (continuous, lifelong).

Classifying Causes of Male Infertility

  • Three anatomical levels
    • Pre-testicular (endocrine/hypothalamic-pituitary)
    • Testicular (intrinsic to the gonad)
    • Post-testicular (ductal transport & maturation)
  • Temporal origin
    • Congenital (present from birth)
    • Acquired (develop later)
  • Terminology
    • Idiopathic male infertility: abnormal semen parameters but no identifiable aetiology.
    • Unexplained male infertility: normal semen parameters & no male/female cause found.

Pre-testicular (Endocrine) Factors

  • Key hormones: FSH, LH ("gonadotropins")
    • Reduced FSH/LH → hypogonadotropic hypogonadism.
      • Congenital example: Kallmann ("Pullman") syndrome.
      • Acquired: malnutrition, excessive exercise, systemic illness suppress GnRH pulsatility.
  • Consequence: ↓ intratesticular testosterone & impaired spermatogenesis.

Testicular Factors

  • Chromosomal
    • Klinefelter syndrome (XXY): subtle phenotype, frequently diagnosed during infertility work-up.
    • Y-chromosome microdeletions (AZF regions) → severe oligozoospermia/azoospermia; often sole symptom is infertility.
  • Acquired gonadal injury
    • Trauma, orchitis, torsion, testicular cancer.
    • Varicocele (pampiniform venous plexus dilation): common in fertile men but over-represented in infertile cohort; may increase scrotal temperature.
    • Infections/inflammation.

Post-testicular Factors

  • Congenital bilateral absence of vas deferens (CBAVD) – often CFTR-related.
  • Obstructive pathologies (epididymis, vas, ejaculatory ducts).
  • Systemic disease or epididymal inflammation during storage phase (DNA damage hotspot).
  • Lifestyle / environmental influences on maturing or ejaculated sperm
    • Smoking, alcohol, recreational drugs, toxins.
    • Medications: certain antibiotics, NSAIDs, antidepressants, chemotherapy, radiation.
    • Heat (sauna, laptops), obesity, advanced paternal age (quality starts to decline ≈ 40–45 y, gradual).

Evaluating Male Fertility

Clinical work-up

  • History, examination, lifestyle review, serum hormones.

Semen Analysis (WHO cornerstone)

  • Laboratory steps
    • Macroscopy: volume, viscosity, pH.
    • Microscopy: concentration & motility counted on haemocytometer; morphology on stained smear.
  • Counting example
    • Count ext{\le}200 sperm across 10 haemocytometer rows → derive concentration (million ml⁻¹).

WHO 2021 Lower Reference Limits (5th percentile of \approx4000 proven fertile men)

  • Semen volume < 1.4 ml → hypospermia.
  • Sperm concentration < 16 million ml⁻¹ OR total count < 39 million → oligozoospermia (none = azoospermia).
  • Progressive motility < 30\% → asthenozoospermia.
  • Normal morphology < 4\% → teratozoospermia.
  • Combination: Oligo-Astheno-Terato-zoospermia (OAT).
  • If all parameters ≥ limits → normozoospermia.

Interpretative Caveats

  • Limits describe the sample, not the patient or aetiology.
  • Natural intra-individual variability; illness or abstinence interval can transiently lower quality.
  • Inter / intra-observer variation in manual counts.
  • \approx15\% of infertile men show normal semen analysis (limitation in sensitivity).
  • Semen analysis does NOT assess
    • Capacitation capability, acrosome reaction, zona binding.
    • Genomic integrity (DNA fragmentation).

Sperm DNA Fragmentation (SDF)

  • Definition: single or double-strand DNA breaks in sperm nucleus.
  • Timing
    • During testicular spermatogenesis.
    • Predominantly during epididymal maturation/storage (most vulnerable phase).
    • Post-ejaculation (cryopreservation, prolonged in vitro incubation).
  • Mechanism: Oxidative stress
    • Reactive Oxygen Species (ROS) generated by metabolically active sperm, leukocytes, immature cells with residual cytoplasm.
    • Antioxidants in epididymal fluid & seminal plasma buffer ROS; imbalance → lipid peroxidation (affects motility) & DNA breaks.

Laboratory Tests

  • TUNEL assay (Concept Fertility standard)
    • Brown nuclei = fragmented; blue = intact → calculate % SDF.
  • Alternatives: SCSA, HALO, COMET; lack direct comparability (e.g., 20\% TUNEL ≠ 20\% SCSA).

Clinical Debate: Routine vs Selective SDF Testing

Pros

  • Adds genomic integrity information absent from standard semen analysis.
  • Potentially modifiable: smoking cessation, antioxidant therapy, frequent ejaculation (< 2 day abstinence).
  • May guide ART strategy (IUI vs IVF vs ICSI).
  • Associations with recurrent pregnancy loss & poor embryogenesis (paternal genome activates day 2–3; oocyte repair may be overwhelmed).
    Cons
  • Heterogeneous assays & cutoff definitions; evidence synthesis difficult.
  • Management guidelines for high SDF remain uncertain.
  • Additional financial cost; ethical concern over "IVF add-ons" without robust benefit proof.
  • Suggested selective use
    • Clinical varicocele assessment
    • Unexplained infertility with normal semen analysis
    • Recurrent miscarriage cases.

Population-Level Sperm Count Debate

  • 2017 meta-analysis: linear sperm count decline of \approx52\% from 1973–2011; speculative link to environmental endocrine disruptors; media extrapolation to "zero sperm by 2045".
  • 2021 critique: proposes "bio-variability" hypothesis
    • Decline remains above WHO thresholds (mean 47 million ml⁻¹); may reflect natural temporal variability, not pathology.
    • No demonstrated parallel drop in global fertility rates attributable solely to sperm parameters.
    • Calls for more longitudinal, mechanistic research.

Key Numerical & Terminology Glossary

  • Spermatogenic cycle duration ≈ 74 days.
  • WHO lower reference limits: Volume 1.4 ml; Conc. 16 M ml⁻¹; Total 39 M; Prog. motility 30\%; Morphology 4\%.
  • OAT: Oligo (<16 M ml⁻¹), Astheno (<30\% prog), Terato (<4\% normal forms).
  • High SDF often defined >20–30\% (assay-specific).

Overall Recap

  • Spermatogenesis is continuous, multi-stage, finishing in epididymis over \approx74 days.
  • Male infertility causes are anatomically & temporally classified; many remain idiopathic or unexplained.
  • Semen analysis, despite observer & biological variability, is the diagnostic cornerstone, utilising WHO fifth-percentile thresholds.
  • DNA fragmentation testing probes deeper sperm quality but its universal application remains controversial; presently advised in select clinical contexts.
  • Headlines on an impending sperm-count "apocalypse" are likely overstated; current data still fall within fertile ranges, though ongoing monitoring is prudent.